KBC Group
BLUE

KBC Group’s bluebird bio BLUE Stock Holding History

KBC Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-234
Closed -$58K – 1292
2021
Q3 		$58K Sell
234
-17,272
-99% -$4.94M ﹤0.01% 1224
2021
Q2 		$7.25M Buy
17,506
+6,537
+60% +$2.59M 0.03% 421
2021
Q1 		$4.28M Buy
10,969
+3,589
+49% +$1.77M 0.02% 489
2020
Q4 		$4.14M Buy
7,380
+1,760
+31% +$1.12M 0.02% 500
2020
Q3 		$3.93M Buy
5,620
+2,606
+86% +$2.03M 0.02% 455
2020
Q2 		$2.38M Buy
3,014
+457
+18% +$345K 0.02% 522
2020
Q1 		$1.52M Buy
2,557
+34
+1% +$33.1K 0.01% 610
2019
Q4 		$2.87M Buy
2,523
+687
+37% +$747K 0.02% 588
2019
Q3 		$2.18M Buy
1,836
+395
+27% +$603K 0.02% 625
2019
Q2 		$2.38M Buy
1,441
+86
+6% +$149K 0.02% 571
2019
Q1 		$2.76M Sell
1,355
-60
-4% -$106K 0.02% 534
2018
Q4 		$1.82M Buy
1,415
+240
+20% +$368K 0.02% 567
2018
Q3 		$2.22M Buy
1,175
+306
+35% +$632K 0.02% 637
2018
Q2 		$1.77M Buy
869
+127
+17% +$289K 0.02% 633
2018
Q1 		$1.64M Sell
742
-119
-14% -$303K 0.02% 619
2017
Q4 		$1.99M Sell
861
-30
-3% -$60.9K 0.02% 601
2017
Q3 		$1.58M Sell
891
-341
-28% -$476K 0.01% 672
2017
Q2 		$1.68M Buy
1,232
+308
+33% +$372K 0.02% 635
2017
Q1 		$1.09M Hold
924
– – 0.01% 846
2016
Q4 		$738K Hold
924
– – 0.01% 930
2016
Q3 		$811K Hold
924
– – 0.01% 833
2016
Q2 		$518K Hold
924
– – 0.01% 865
2016
Q1 		$509K Buy
924
+485
+110% +$298K 0.01% 835
2015
Q4 		$366K Buy
439
+144
+49% +$144K 0.01% 870
2015
Q3 		$326K Buy
295
+63
+27% +$115K 0.01% 881
2015
Q2 		$505K Buy
+232
New +$473K 0.01% 888

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KBC Group's BLUE Position: Q4 2021 in Review

KBC Group sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 234 shares — an estimated $58K sold.

KBC Group first reported a position in BLUE in Q2 2015 and held it in 26 quarters. The position peaked at $7.25M in Q2 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • KBC Group reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • KBC Group sold 234 bluebird bio shares in Q4 2021, an estimated $58K.
  • KBC Group first reported a position in bluebird bio in Q2 2015 and held it in 26 quarters.
  • KBC Group's bluebird bio position peaked at $7.25M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on KBC Group's 13F filing for Q4 2021, filed 3 Feb 2022.